NPI: 1588695514 · BROOKSVILLE, FL 34601 · General Acute Care Hospital · NPI assigned 07/06/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 07/06/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,197 | $163K |
| 2019 | 39,109 | $505K |
| 2020 | 34,317 | $428K |
| 2021 | 42,162 | $967K |
| 2022 | 39,735 | $1.47M |
| 2023 | 18,491 | $696K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,112 | 12,413 | $1.23M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 9,556 | 8,053 | $577K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,854 | 3,542 | $434K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,669 | 1,503 | $296K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,948 | 2,329 | $251K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,859 | 3,094 | $249K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,086 | 936 | $183K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,388 | 2,206 | $170K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3,236 | 2,685 | $124K |
| 36415 | Collection of venous blood by venipuncture | 11,567 | 8,043 | $122K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,666 | 1,473 | $96K |
| 72125 | Computed tomography, cervical spine; without contrast material | 992 | 756 | $40K |
| G0378 | Hospital observation service, per hour | 1,374 | 953 | $39K |
| 80053 | Comprehensive metabolic panel | 11,723 | 8,951 | $38K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,089 | 806 | $34K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,393 | 2,071 | $32K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 123 | 104 | $30K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,838 | 2,439 | $29K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,111 | 2,635 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,287 | 1,045 | $17K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,273 | 1,944 | $14K |
| 71045 | Radiologic examination, chest; single view | 4,866 | 4,020 | $13K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,792 | 1,653 | $13K |
| 71046 | Radiologic examination, chest; 2 views | 1,514 | 1,365 | $12K |
| 81001 | 6,241 | 5,334 | $11K | |
| 85610 | 4,636 | 3,686 | $9K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,366 | 1,785 | $9K |
| 73630 | 319 | 296 | $8K | |
| 81003 | 1,654 | 1,456 | $8K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 174 | 128 | $8K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,725 | 2,359 | $8K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 11,906 | 8,908 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,265 | 4,149 | $7K |
| 84484 | 4,179 | 2,653 | $6K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 96 | 24 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 681 | 588 | $6K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5,689 | 4,767 | $6K |
| 85730 | 4,239 | 3,400 | $5K | |
| 83735 | 5,183 | 3,682 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 3,933 | 3,181 | $4K |
| 73564 | 197 | 171 | $4K | |
| 73130 | 142 | 121 | $4K | |
| 73610 | 168 | 152 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,378 | 2,773 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,237 | 841 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,622 | 2,204 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 268 | 239 | $2K |
| 85027 | 1,052 | 748 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,344 | 1,901 | $2K |
| 73030 | 186 | 146 | $2K | |
| 83690 | 3,292 | 2,825 | $2K | |
| 87428 | 1,103 | 1,027 | $1K | |
| 82962 | 879 | 383 | $1K | |
| 96376 | 690 | 404 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 797 | 685 | $1K |
| 82550 | 1,588 | 1,142 | $1K | |
| 83880 | 1,446 | 1,200 | $1K | |
| 72131 | 14 | 13 | $1K | |
| 84703 | 423 | 378 | $820.78 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,095 | 745 | $818.69 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 30 | 25 | $752.06 |
| 93971 | 45 | 40 | $493.46 | |
| 87040 | 575 | 319 | $364.26 | |
| 85379 | 865 | 753 | $352.32 | |
| 82150 | 472 | 424 | $351.16 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,070 | 795 | $350.81 |
| 76830 | Ultrasound, transvaginal | 16 | 12 | $345.74 |
| 87186 | 585 | 486 | $274.18 | |
| 87807 | 512 | 483 | $268.47 | |
| 82553 | 938 | 722 | $234.96 | |
| 84443 | Thyroid stimulating hormone (TSH) | 439 | 354 | $181.09 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 41 | 39 | $171.46 |
| 86901 | 29 | 25 | $141.41 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 333 | 270 | $113.91 |
| 86140 | 60 | 52 | $113.85 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 156 | 130 | $113.45 |
| 87210 | 12 | 12 | $110.22 | |
| 80061 | Lipid panel | 342 | 255 | $106.30 |
| 82077 | 556 | 465 | $97.89 | |
| 81025 | 1,100 | 983 | $52.04 | |
| C9113 | Injection, pantoprazole sodium, per vial | 146 | 114 | $48.53 |
| 86900 | 14 | 12 | $33.33 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 41 | 39 | $27.84 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 24 | 13 | $25.00 |
| 87077 | 412 | 340 | $14.15 | |
| 94760 | 560 | 439 | $1.74 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 97 | 80 | $1.74 |
| 83605 | 266 | 208 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 337 | 296 | $0.00 |
| 87081 | 834 | 760 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 153 | 103 | $0.00 |
| 87430 | 966 | 888 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 33 | 29 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 40 | 37 | $0.00 |
| 83615 | 14 | 13 | $0.00 | |
| 87070 | 14 | 12 | $0.00 | |
| 87147 | 18 | 15 | $0.00 | |
| 85651 | 18 | 16 | $0.00 | |
| 80143 | 142 | 118 | $0.00 | |
| 84702 | 62 | 53 | $0.00 | |
| 80179 | 109 | 91 | $0.00 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 12 | 12 | $0.00 |